# eGain Corporation (EGAN) · Edgar & Edgarette company card

> eGain (EGAN) grew revenue 3.1% in FY2026 to $91 million, operating margin 8.7% against a 0.9% median for prepackaged software, equity 56.9% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1066194 · fiscal year ended 2026-06-30 · 5 audited years read · [page](https://www.pops4.com/boards/company/EGAN) · [JSON](https://www.pops4.com/boards/company/EGAN.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $91M |
| Revenue growth, 1 year | 3.1% |
| Revenue growth per year | -0.2% |
| Operating margin | 8.7% (prior year 5.0%) |
| Net margin | 9.7% |
| Operating cash flow | $21M |
| Capital spending | $617,000 |
| Free cash flow | $21M |
| Cash | $73M |
| Long-term debt | — |
| Total assets | $148M |
| Total equity | $84M |
| Equity ÷ assets | 56.9% |
| Return on equity | 10.5% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -2.57 (distress zone)
- Piotroski F: 8 of 9 (strong)
- Health Harbor boat: Sound ship · one warning sign · revenue is hard to predict: its 80% range is ±28%
- Cash Compass: In between · no clear cash pattern yet

## Edgarette's reading

Exposure: revenue $91.1M (FY2026). Experience: revenue up 3.1% on the year, down 0.2% a year over 4 years; operating margin 8.7%, up from 5.0%. Soundness: equity 56.9% of assets, return on equity 10.5%. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $66.9M and $117.7M next year (method v4.1: its own 6-year record of growth weighed at 63% against $50M–100M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $68.3M to $115.4M. A statistical range, not company guidance. Against peers (140 filers, $50M+ revenue, services-prepackaged software): operating margin 8.7% against a 0.9% median; growth 3.1% against 13.0%.

Range logged 2026-10-14, receipt c5d97cf4fb3f75a8, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 1, latest 2026-11-05 ([filing](https://www.sec.gov/Archives/edgar/data/1066194/000106619426000017/0001066194-26-000017-index.htm))

## Recent filings

- 10-Q · filed 2026-11-13 · [filing](https://www.sec.gov/Archives/edgar/data/1066194/000110465926127101/0001104659-26-127101-index.htm)
- 8-K · filed 2026-11-05 · 2.02 Results of Operations and Financial Condition; 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1066194/000106619426000017/0001066194-26-000017-index.htm)
- DEF 14A · filed 2026-10-13 · [filing](https://www.sec.gov/Archives/edgar/data/1066194/000110465926115474/0001104659-26-115474-index.htm)
- 10-K · filed 2026-09-10 · [filing](https://www.sec.gov/Archives/edgar/data/1066194/000110465926106739/0001104659-26-106739-index.htm)
- 8-K · filed 2026-09-03 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1066194/000106619426000014/0001066194-26-000014-index.htm)
- 10-Q · filed 2026-05-14 · [filing](https://www.sec.gov/Archives/edgar/data/1066194/000110465926061184/0001104659-26-061184-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001066194.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1066194

## Cite

POPS4, Edgar & Edgarette: eGain Corporation (EGAN) company card, from the company's own SEC filings, accessed 2026-11-18, https://www.pops4.com/boards/company/EGAN. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

